265 related articles for article (PubMed ID: 19944964)
1. Glioblastoma-derived mechanisms of systemic immunosuppression.
Waziri A
Neurosurg Clin N Am; 2010 Jan; 21(1):31-42. PubMed ID: 19944964
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of immunomodulation in human glioblastoma.
Avril T; Vauleon E; Tanguy-Royer S; Mosser J; Quillien V
Immunotherapy; 2011 Apr; 3(4 Suppl):42-4. PubMed ID: 21524170
[TBL] [Abstract][Full Text] [Related]
3. Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics.
Kronik N; Kogan Y; Vainstein V; Agur Z
Cancer Immunol Immunother; 2008 Mar; 57(3):425-39. PubMed ID: 17823798
[TBL] [Abstract][Full Text] [Related]
4. Heat shock proteins in glioblastomas.
Yang I; Fang S; Parsa AT
Neurosurg Clin N Am; 2010 Jan; 21(1):111-23. PubMed ID: 19944971
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil degranulation and immunosuppression in patients with GBM: restoration of cellular immune function by targeting arginase I.
Sippel TR; White J; Nag K; Tsvankin V; Klaassen M; Kleinschmidt-DeMasters BK; Waziri A
Clin Cancer Res; 2011 Nov; 17(22):6992-7002. PubMed ID: 21948231
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy for glioma: promises and challenges.
Han SJ; Zygourakis C; Lim M; Parsa AT
Neurosurg Clin N Am; 2012 Jul; 23(3):357-70. PubMed ID: 22748649
[TBL] [Abstract][Full Text] [Related]
7. Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment.
Pearson JRD; Cuzzubbo S; McArthur S; Durrant LG; Adhikaree J; Tinsley CJ; Pockley AG; McArdle SEB
Front Immunol; 2020; 11():582106. PubMed ID: 33178210
[TBL] [Abstract][Full Text] [Related]
8. Brain cancer immunoediting: novel examples provided by immunotherapy of malignant gliomas.
Pellegatta S; Cuppini L; Finocchiaro G
Expert Rev Anticancer Ther; 2011 Nov; 11(11):1759-74. PubMed ID: 22050025
[TBL] [Abstract][Full Text] [Related]
9. The network of immunosuppressive pathways in glioblastoma.
Mangani D; Weller M; Roth P
Biochem Pharmacol; 2017 Apr; 130():1-9. PubMed ID: 28017775
[TBL] [Abstract][Full Text] [Related]
10. Vaccination elicits correlated immune and clinical responses in glioblastoma multiforme patients.
Wheeler CJ; Black KL; Liu G; Mazer M; Zhang XX; Pepkowitz S; Goldfinger D; Ng H; Irvin D; Yu JS
Cancer Res; 2008 Jul; 68(14):5955-64. PubMed ID: 18632651
[TBL] [Abstract][Full Text] [Related]
11. [Immunology and immunotherapy of cerebral tumors. Current status].
Trouillas P
Rev Neurol (Paris); 1973 Jan; 128(1):23-38. PubMed ID: 4367367
[No Abstract] [Full Text] [Related]
12. Immunosuppressive mechanisms in glioblastoma.
Nduom EK; Weller M; Heimberger AB
Neuro Oncol; 2015 Nov; 17 Suppl 7(Suppl 7):vii9-vii14. PubMed ID: 26516226
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of local immunoresistance in glioma.
Albesiano E; Han JE; Lim M
Neurosurg Clin N Am; 2010 Jan; 21(1):17-29. PubMed ID: 19944963
[TBL] [Abstract][Full Text] [Related]
14. Cold Atmospheric Plasma as an Adjunct to Immunotherapy for Glioblastoma Multiforme.
Almeida ND; Klein AL; Hogan EA; Terhaar SJ; Kedda J; Uppal P; Sack K; Keidar M; Sherman JH
World Neurosurg; 2019 Oct; 130():369-376. PubMed ID: 31284051
[TBL] [Abstract][Full Text] [Related]
15. Achieving graft-versus-tumor effect in brain tumor patients: from autologous progenitor cell transplant to active immunotherapy.
Petrosiute A; Auletta JJ; Lazarus HM
Immunotherapy; 2012 Nov; 4(11):1139-51. PubMed ID: 23194364
[TBL] [Abstract][Full Text] [Related]
16. Computational Characterization of Suppressive Immune Microenvironments in Glioblastoma.
Luoto S; Hermelo I; Vuorinen EM; Hannus P; Kesseli J; Nykter M; Granberg KJ
Cancer Res; 2018 Oct; 78(19):5574-5585. PubMed ID: 29921698
[TBL] [Abstract][Full Text] [Related]
17. Developing immunotherapeutic strategies to target brain tumors.
Lieberman NA; Moyes KW; Crane CA
Expert Rev Anticancer Ther; 2016 Jul; 16(7):775-88. PubMed ID: 27253692
[TBL] [Abstract][Full Text] [Related]
18. Understanding the role of cytokines in Glioblastoma Multiforme pathogenesis.
Zhu VF; Yang J; Lebrun DG; Li M
Cancer Lett; 2012 Mar; 316(2):139-50. PubMed ID: 22075379
[TBL] [Abstract][Full Text] [Related]
19. Proceedings: Immunological investigations on human brain tumor patients.
Mahaley MS
Proc Natl Cancer Conf; 1972; 7():811-5. PubMed ID: 4358071
[No Abstract] [Full Text] [Related]
20. [Immunology of brain tumors (author's transl)].
Takakura K
No To Shinkei; 1976 Jun; 28(6):525-37. PubMed ID: 194610
[No Abstract] [Full Text] [Related]
[Next] [New Search]
